Prenetics Global Ltd
PRE · XNASCIK 1876431fmd_0S4HN7MH7F9B8DXHXYRBY34ZASManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Dec 31, 2025, 6 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Total revenues | 65 | 13 | 13 | 22 | 31 |
| Cost of revenue | 39 | 9 | 10 | 13 | 15 |
| Gross profit | 26 | 4 | 4 | 9 | 15 |
| Research and development | 3 | 6 | 6 | 12 | 11 |
| Operating income | (1) | (57) | (66) | (52) | (48) |
| Interest expense | 0 | 5 | 4 | – | – |
| Income before taxes | (4) | (217) | (226) | (57) | (58) |
| Income tax expense | (2) | 3 | (0) | (0) | (8) |
| Net income from continuing operations | (2) | (219) | (226) | (56) | (50) |
| Net income | (2) | (174) | (190) | (63) | (46) |
| Net income to common shareholders | – | – | (190) | (63) | (46) |